How Does This Health Giant Operate?
CVS Health is a large U.S. health care company that combines pharmacy services with a broad retail pharmacy footprint. It fills prescriptions, sells health and wellness products through its stores, and provides pharmacy-related services at scale. The business sits at the intersection of everyday consumer health needs and the more complex flow of prescription fulfillment. With a market cap around USD 93.5 billion, it operates at a size where small changes in unit economics can matter.
Are Thin Margins Limiting Profit Growth?
FundamentalsFor 2025 (reported in USD), CVS Health generated revenue of about USD 265.1 billion, alongside EBIT of USD 4.7 billion and net income of roughly USD 1.7 billion. Revenue grew 7.0% year over year, while profitability stayed tight in the trailing picture, with a 13.77% gross margin narrowing to a 1.28% operating margin and a 0.44% net profit margin.
Cash on the balance sheet was USD 8.5 billion against total debt of USD 5.8 billion. Depreciation and amortization ran at about USD 4.6 billion, and the company’s cash flow proxy came in near USD 8.9 billion.
Is The Market Underpricing Future Cash Flow?
DCF / MultiplesAt USD 73.49, the share price sits below the modeled fair value range based on discounted cash flow analysis. The headline multiples attached to the current price include a 52.88 trailing P/E and 28.47 EV/EBITDA, alongside a 0.23 price-to-sales ratio.
Growth Needs Better Leverage
TakeawayThe price is asking for more than thin margins can comfortably deliver. The case works if revenue growth stays steady and cash holds up. Reinvestment needs to translate into better operating leverage over time. If margins stay pinned near current levels, progress will feel slow. A stumble in earnings quality could quickly change the narrative.